New Alzheimer's vaccine trial aims to slow memory loss
NCT ID NCT07167966
Summary
This study is testing whether a vaccine called AADvac1 can slow the progression of Alzheimer's disease in its earliest stages. It will involve 375 adults aged 50-80 who have very early signs of the disease. The vaccine targets a protein called tau, and researchers will see if it works better alone or when combined with another Alzheimer's drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.